---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036905"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2026-08-10T21:07:05+00:00"
generated_at: "2026-08-10T21:08:15.755854+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals to release Q1 FY2027 results Aug 13; earnings call Aug 14

## Summary
- Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
- Conference call Friday, August 14, 2026, 11:30 AM EDT; dial-in 1-800-346-7359 (domestic) or 1-973-528-0008 (international).
- Conference number 98840; general questions due Aug 12, financial questions due Aug 13 via dianne@elitepharma.com.
- Call to cover financial/operating results and provide a general business update; audio replay available at elite.irpass.com.
- Company develops and distributes niche generic oral controlled-release products from Northvale, NJ facility.

## SEC filing metadata
- accession: 0001493152-26-036905
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2026-08-10T21:07:05+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315226036905/0001493152-26-036905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315226036905/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036905
- JSON: https://secwatch.observer/filing/0001493152-26-036905.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.